Core Insights - Ant Group's CEO, Han Xinyi, emphasized the company's commitment to AI in healthcare, aiming to simplify medical access and promote healthier living [1][4] - The establishment of the Health Business Group marks a strategic shift for Ant Group, focusing on addressing the growing health demands of the population [1][4] Group 1: Health Demand and AI Solutions - The health needs of the public are escalating, with over 500 million chronic disease patients in China facing low awareness, treatment, and control rates [3] - Ant Group's AI health application, AQ, launched in June, has surpassed 10 million monthly active users within four months, achieving a compound growth rate of 83.4%, the highest in the industry [3][4] - The application offers over a hundred AI features, including health education, consultation, report interpretation, and health records management [3] Group 2: Enhancing Medical Services - Ant Group collaborates with top-tier hospitals to create over 300 "famous doctor AI avatars," significantly increasing access to quality medical services for patients in remote areas [4] - The AI avatars have already served over 6.5 million insomnia patients, far exceeding the annual in-person consultation numbers of the hospitals [4] - The company is also focusing on chronic disease management by providing personalized health management services to over 500 million chronic disease patients [4] Group 3: Strategic Partnerships and Future Goals - Ant Group has partnered with Sichuan University West China Hospital to enhance research and service systems for chronic diseases like lung nodules [4] - The company aims to bridge the gap between AI medical research and clinical application, addressing the "last mile" challenge in healthcare [4] - Han Xinyi reiterated the company's mission to leverage technology to solve social health issues, reinforcing the strategic importance of the Health Business Group [4]
蚂蚁集团CEO韩歆毅：AQ承载蚂蚁健康新使命，让看病更简单、生活更健康